Researchmoz Global Pvt. Ltd.

Recombinant Coagulation Factors 2015 Market Research Report Share

Most up-to-date research on "Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants" to its huge collection of research reports.


Albany, NY -- (SBWIRE) -- 01/16/2015 -- This report provides an update of recombinant coagulation factors used for controlling bleeding of hemophilia A and B and other bleeding disorders. 2013 sales figures and 2014 nine-month sales data are analyzed to evaluate commercial development of the market under the light of a strong pipeline and entry of new competitor products into the market. The profiles of drug candidates in development are presented in details not only for recombinant coagulation factors VIII, IX and VII, but also for emerging alternative procoagulants, gene therapeutics and immune tolerance inducing agents.

Browse Detail Report With TOC @

The competitve landscape of classical recombinant coagulation factors and of new emerging treatment modalities of hemophilia and other severe bleeding orders is analyzed. The emergence of new treatment modalities brings many new stakeholders to the field of hemophilia. Among them are the established hemophilia portofolio companies, but also new entrants from Big Pharma and Big Biotech, specialty pharmaceutical companies, biosimilar companies, and new technology providers as half-life prolongation technologies are no longer in the focus of major interest.

Request for Sample Report @

A short- to mid-term outlook into the field is provided and the trends driving the future of this therapeutic segment are identified and described. Preparation of this report is based on information stored in La Merie Publishing's proprietary data base and news archive, on scientific literature, and on corporate disclosures. The data are presented, analyzed and assessed in a comprehensive manner by an experienced author with an independent view writing the fifth edition of this report series.

Benefits from the report:

Development of product sales and recombinant coagulation factors market
Sales performance of newly launched recombinant coagulation factors
Drug profiles for all relevant classical as well a semerging developments
Technologies, constructs and players in the gene therapy field of hemophilia
Alternative procoagulants: approaches, profiles, competitive advantages
Comparative analysis of key product features of new coagulation factors
Corporate profiles of all relevant stakeholders including deals and pipelines
Pipeline and technology trends

For Market Research Latest Reports Visit @

Related Reports
Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)
Scope of the Report The report titled "Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)" provides an insight into the glaucoma treatment market over the years with a special focus on major categories- pharmaceuticals and devices. The report includes detailed information on market size and share by type of drugs in glaucoma treatment sector. It also...

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies
GBI Research, the leading business intelligence provider, has released its latest research: 'Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies ', which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for...

For More Reports Browse @

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact: